Periscope Capital’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Periscope Capital’s Portfolio EBACW Stock Details EBACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-196,896	Closed	-$57.6K	–	908
2022 Q4	$57.6K	Buy	196,896 +37,096	+23%	+$7.47K	﹤0.01%	550
2022 Q3	$11K	Buy	159,800 +5,000	+3%	+$546	﹤0.01%	993
2022 Q2	$15K	Hold	154,800	–	–	﹤0.01%	1035
2022 Q1	$31K	Hold	154,800	–	–	﹤0.01%	1052
2021 Q4	$88K	Buy	+154,800	New	+$98.9K	﹤0.01%	856

Periscope Capital's EBACW Position: Q1 2023 in Review

Periscope Capital sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 196,896 shares — an estimated $57.6K sold.

Periscope Capital first reported a position in EBACW in Q4 2021 and held it in 5 quarters. The position peaked at $88K in Q4 2021. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

Periscope Capital reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Periscope Capital sold 196,896 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $57.6K.
Periscope Capital first reported a position in European Biotech Acquisition Corp. Warrant in Q4 2021 and held it in 5 quarters.
Periscope Capital's European Biotech Acquisition Corp. Warrant position peaked at $88K in Q4 2021.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on Periscope Capital's 13F filing for Q1 2023, filed 12 May 2023.